{"title": "FIRST EVER DENGUE VACCINE CANDIDATE TO SHOW EFFICACY AGAINST DENGUE FEVER AND DENGUE HAEMORRHAGIC FEVER IN ASIA", "author": "Damian Garde", "url": "https://www.fiercebiotech.com/biotech/first-ever-dengue-vaccine-candidate-to-show-efficacy-against-dengue-fever-and-dengue", "hostname": "fiercebiotech.com", "description": "- 88.5% reduction of Dengue Haemorrhagic Fever shown in detailed analyses of world's first phase III efficacy study published in The Lancet - - Two thirds reduction in hospitalization observed... | - 88.5% reduction of Dengue Haemorrhagic Fever shown in detailed analyses of world's first phase III efficacy study published in The Lancet - - Two thirds reduction in hospitalization observed...", "sitename": "FierceBiotech", "date": "2014-07-11", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}